Hjem › Metaboliske lidelser › Texas
Metaboliske lidelser kliniske forsøg i Texas
7 studier for Metaboliske lidelser søger deltagere på steder i Texas.
Byer i Texas
Officiel studietekst (engelsk)
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- PlanIt Research, LLC (Monitoring Room), Houston
- PlanIt Research, LLC, Houston
- VIP Trials, San Antonio
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07595549A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Amarillo
- 89bio Clinical Study Site, Austin
- 89bio Clinical Study Site, Austin
- og 30 flere
RekruttererFase 3
Alder 18 til 80 · Alle køn · Opdateret 3. sep. 2026 · NCT06318169A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Amarillo
- 89bio Clinical Study Site, Austin
- 89bio Clinical Study Site, Austin
- og 21 flere
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 3. sep. 2026 · NCT06419374Genetic and Metabolic Disease in Children
- Children's Medical Center at Dallas, Dallas
RekruttererObservationsstudie
1 Day · Alle køn · Opdateret 2. jul. 2026 · NCT02650622A Study to Assess the Long-term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 Study
- Texas Children's Hospital, Houston
RekruttererFase 1/2
Alder 1 og opefter · Alle køn · Opdateret 23. mar. 2026 · NCT05130437Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
- Texas Children's Hospital, Houston
RekruttererFase 1/2
Alle aldre · Alle køn · Opdateret 22. jan. 2026 · NCT04159103Rare and Atypical Diabetes Network
- Baylor College of Medicine, Houston
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 14. aug. 2025 · NCT05544266Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.